Now, amid the backlash, which appears to have not died down, UnitedHealth Group CEO Andrew Witty finally addressed Thompson’s ...

The article isn't very linear, so we thought we'd point out some of the highlights and some of the obscure details, and then ...

In a report released yesterday, Guillaume Delaby from Bernstein maintained a Buy rating on Schlumberger (SLB – Research Report), with a price ...

Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...